Obesity, a risk factor of cardiovascular disease;Kardiovaskularer risikofaktor adipositas

Deutsche Medizinische Wochenschrift

Volumn 125, Issue 9, 2000, Pages 262-268

  Laufs, Ulrich ^a   Böhm, Michael ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; GENETIC PREDISPOSITION; HEART VENTRICLE HYPERTROPHY; HYPERLIPIDEMIA; OBESITY; HUMAN; HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; RISK FACTOR;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; OBESITY; RISK FACTORS;

EID: 0034599088     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024089     Document Type: Article

References (46)

1. Albu, J., F. X. Pi-Sunyer: Obesity and diabetes. In: Bay, G.A., C. Bouchard, W.P.T. James (eds.). Handbook of obesity. (M. Dekker, New York 1998), 697-711.
2. Assmann, G., H. Schulte, P. Cullen: New and classical risk factors - The Münster Heart Study (PROCAM). Europ. J. med. Res. 2 (1997) 6.
3. Ault, A.: FDA issues warning on diet-drug combination. Lancet 350 (1997), 189.
4. Cambridge heart antioxidant study group (CHAOS): Randomised trial of vitamin E in patients with coronary disease. Lancet 347 (1996), 781-786.
5. Campfield, L. A., F. S. Smith, P. Burn: Strategies and potential molecular targets for obesity treatment. Science 280 (1998), 1383-1387.
6. Chan, J. M., E. B. Rimm, G. A. Colditz, et al.: Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabet. Care 17 (1994), 961-967.
7. Comuzzie, A. G., D. B. Allison: The search for human obesity genes. Science 280 (1998), 1374-1377.
8. De Divitis, O., S. Fazio, M. Petitto, et al.: Obesity and cardiac function. Circulation 64 (1981), 477-482.
9. Deutsche Adipositas-Gesellschaft: Leitlinien der Deutschen Adipositas- Gesellschaft zur Therapie der Adipositas. Adipositas 16 (1998), 6-28.
10. Deutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung: Leitlinie: Koronare Herzkrankheit/Angina pectoris. Z. Kardiol. 87 (1998), 907-911.
11. Deutsche Hypertonie Gesellschaft: Übergewicht und Hochdruck, Merkblatt. (Deutsche Hypertonie Gesellschaft, Heidelberg, 1999).
12. Friedman, J. M., J. L. Halaas: Leptin and the regulation of body weight in mammals. Science 395 (1998), 763-770.
13. Frost, G., A. A. Leeds, C. J. Dore, et al.: Glycaemic index as a determinant of serum HDL-choIesterol concentration. Lancet 353 (1999), 1045-1048.
14. Harris, T., E. F. Cook, R. Garrison, et al.: Body mass index and mortality among nonsmoking older persons. The Framingham Heart Study. JAMA 259 (1988), 1520-1524.
15. Hauner, H: Adipositas und Leptin. Dtsch. med. Wschr. 123 (1998), 1315-1318.
16. Hoffmeister, H., G.B.M. Mensink, H. Stolzenberg: National trends in risk factors for cardiovascular disease in Germany. Prevent. Med. 23 (1994) 197-201.
17. Hofstetter, A., Y. Schulz, E. Jequier, J. Wahren: Increased 24-h energy expenditure in cigarette smokers. New Engl. J. Med. 314 (1986), 79-82.
18. Hu, F. B., M. J. Stampfer, E. B. Rimm, et al.: A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 281(1999), 1387-1394.
19. Kasper, E. K., R. H. Hruban, K. L. Baughman: Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. Amer. J. Cardiol. 70 (1992), 921-924.
20. Kiberstis, P. A., J. Marx: Regulation of body weight. Science 280 (1998), 1363-1370.
21. Kushi, L. H., A. R. Folsom, R. J. Prineas: Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. New Engl. J. Med. 334 (1996), 1156-1162.
22. Laufs, U.: "Fettfreies Fett Olestra" in den USA zugelassen. Dtsch. Ärztebl. 93 (1996), 213.
23. Lean M. E. J., T. S. Han, C. E. Morrison: Waist as a measure for indicating need for weight management. Brit. med. J. 311 (1995) 158-160.
24. Leibel, R. L. et al.: Changes in energy expenditure resulting from altered body weight. New Engl. J. Med. 332 (1995), 621-628.
25. Levine, J. A., N. L. Eberhardt, M. D. Jensen: Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 283 (1999) 212-214.
26. Lichtenstein, A. H., L. M. Ausman, S. M. Jalbert, et al.: Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. New Engl. J. Med. 340 (1999) 1933-1940.
27. Manson, J. E., W. C. Willett, M. J. Stampfer: Body weight and mortality among women. New Engl. J. Med. 333 (1995), 677-685.
28. Messerli, F. H.: Cardiovascular effects of obesity and hypertension. Lancet 22 (1982), 1165-1168.
29. National Institutes of Health: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. NIH Publications Nr. 98-4083 (1998).
30. Rand, C. S. W., A. M. C. McGregor: Morbidly obese patient's perceptions of social discrimination before and after surgery for obesity. South. med. J. 83 (1990) 1390-1398.
31. Rexrode, K. M., C. H. Hennekens, W. C. Willett, et al.: A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 277 (1997) 1539-1544.
32. Ryan, D. H., P. Kaiser, G. A. Bray: Sibutramine: A novel new agent for obesity treatment. Obesity Res. 3 (1995), 553s-559s.
33. Second joint task force of European and other societies on coronary prevention: Prevention of coronary heart disease in clinical practice. Europ. Heart J. 19 (1998), 1434-1503.
34. Sjöström, L., A. Rissanen, T. Andersen, et al. for the European Multi-centre Orlistat Study Group: Randomised placebo-controlled trial of orlistat for weight loss and prevention of weigth regain in obese patients. Lancet 352 (1998), 167-173.
35. Stone, N. J.: Diet, nutritional issues, and obesity. Textbook of Cardiovascular Medicine. E. J. Topol (Ed.). (Lippincott-Raven, Philadelphia 1998), 31-58.
36. Suter, P. M., Y. Schulz, E. Jequier. The effect of ethanol on fat storage in healthy subjects. New Engl. J. Med. 326 (1992), 983-987.
37. Toubro, S., A. Astrup: Randomised comparison of diets for maintaining obese subjects' weight after major weight loss. Brit. med. J. 314 (1997), 29-34.
38. Walker, S. P., E. B. Rimm, Ascherio, et al.: Body size and fat distribution as predictors of stroke among US men. Amer. J. Epidemiol. 144 (1996) 1143-1150.
39. Wechsler, J. G.: Aktuelle Therapie der Adipositas. Dtsch. med. Wschr. 122 (1997), 1287-1290.
40. Weinsier, R. L., G. R. Hunter, et al.: The etiology of obesity. Amer. J. Med. 105 (1998) 145-150.
41. WHO report obesity: Preventing and managing the global epidemic. World Health Organization, Geneva (1998).
42. Willett, W. C., M. L. Browne, C. Bain, et al.: Relative weight and risk of breast cancer among premenopausal women. Amer. J. Epidemiol. 122 (1985) 731.
43. Willett, W. C., et al.: Weight, weight change, and coronary heart disease in women. JAMA 273 (1995) 461-468.
44. Williams, G. H., L. S. Lilly, E. W. Seely: The heart in endocrine and nutritional disorders. In: Braunwald, E. (ed.), Heart disease. (W. B. Saunders: Philadelphia 1997), 1887-1913.
45. Zack, P. M., R. D. Wiens, H. L. Kennedy: Left-axis deviation and adiposity. Amer. J. Cardiol. 53 (1984), 1129-1134.
46. Zhang, Y., R. Proenca, M., et al.: Positional cloning of the mouse ob gene and its human homologue. Nature 372 (1994), 425-432.